Shihe Pharmaceutical Group: Preliminary estimate that the company's attributable profit to equity holders will decrease by 45% to 60% year-on-year by 2025.
Shisuo Pharmaceutical Group announced on the Hong Kong Stock Exchange that the preliminary estimate for the company’s attributable profit to equity holders in 2025 will decrease by 45% to 60% year-on-year, with 2024’s profit at HKD 1.061 billion.
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Shihe Pharmaceutical Group: Preliminary estimate that the company's attributable profit to equity holders will decrease by 45% to 60% year-on-year by 2025.
Shisuo Pharmaceutical Group announced on the Hong Kong Stock Exchange that the preliminary estimate for the company’s attributable profit to equity holders in 2025 will decrease by 45% to 60% year-on-year, with 2024’s profit at HKD 1.061 billion.